Cargando…

Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma

The aim of the present study was to investigate the survival and prognostic factors of patients who were with advanced esophageal squamous cell carcinoma (ESCC) and developed an esophageal fistula. The data from 221 patients with advanced ESCC developed esophageal fistula from January 2008 to Decemb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Xin, Liu, Chao, Zhou, Tianshuo, Ma, Zhigang, Zhang, Chunhui, Wang, Bojun, Yao, Yang, Fan, Xiaona, Li, Zhiwei, Zhang, Yanqiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960064/ https://www.ncbi.nlm.nih.gov/pubmed/31894852 http://dx.doi.org/10.1042/BSR20193379

Ejemplares similares

Prognostic impact of MutT homolog‐1 expression on esophageal squamous cell carcinoma
por: Akiyama, Shingo, et al.
Publicado: (2016)

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
por: He, Wenwu, et al.
Publicado: (2022)

Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer
por: Ma, Lucy X, et al.
Publicado: (2022)

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
por: Wang, Jian‐Hua, et al.
Publicado: (2019)

Esophageal squamous cell carcinoma and prognosis in Taiwan
por: Cheng, Ya‐Fu, et al.
Publicado: (2018)

Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Liu, Yin-Qiao, et al.
Publicado: (2022)

Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma
por: Arora, Mohit, et al.
Publicado: (2023)

Preoperative Prognostic Nutritional Index Predict Survival in Patients With Resectable Esophageal Squamous Cell Carcinoma
por: Zheng, Zhiwei, et al.
Publicado: (2022)

Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor: Findings from the ESCCAPE multicountry case‐control studies
por: Narh, Clement T., et al.
Publicado: (2021)

Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants
por: Chen, Shuchen, et al.
Publicado: (2020)

The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ–Ⅲ esophageal cancer: a SEER‐based demographic analysis
por: Lv, Hao, et al.
Publicado: (2021)

Risk factors for esophageal fistula in patients with locally advanced esophageal carcinoma receiving chemoradiotherapy
por: Zhang, Yang, et al.
Publicado: (2018)

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma
por: Dai, Honghai, et al.
Publicado: (2019)

Risk Factors Associated with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma
por: Hu, Bing, et al.
Publicado: (2020)

Overexpression of SRC‐3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness
por: Xu, Fang‐Ping, et al.
Publicado: (2016)

Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma
por: Xie, Shao‐Hua, et al.
Publicado: (2020)

A three-gene signature and clinical outcome in esophageal squamous cell carcinoma
por: Sun, Ling-Ling, et al.
Publicado: (2015)

Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial
por: Huang, Jing, et al.
Publicado: (2021)

ZFPM2-AS1 facilitates cell growth in esophageal squamous cell carcinoma via up-regulating TRAF4
por: Sun, Gaozhong, et al.
Publicado: (2020)

Esophageal atresia with tracheo-esophageal fistula
por: Chatterjee, Subir K.
Publicado: (2010)

Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma
por: Wang, Shuai, et al.
Publicado: (2018)

Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer
por: Yu, Yue, et al.
Publicado: (2019)

Thoracoscopy for Esophageal Diverticula After Esophageal Atresia With Tracheo-Esophageal Fistula
por: Yong, Zhao, et al.
Publicado: (2021)

Atrio-esophageal fistula clinically presented as pericardial-esophageal fistula
por: Szegedi, Nándor, et al.
Publicado: (2021)

Immunotherapy for Esophageal Squamous Cell Carcinoma
por: Kojima, Takashi, et al.
Publicado: (2017)

Radiosensitization of HER2-positive esophageal cancer cells by pyrotinib
por: Lian, Xiangyao, et al.
Publicado: (2020)

Advanced esophageal cancer with tracheobronchial fistula successfully treated by　esophageal bypass surgery
por: Kimura, Masahiro, et al.
Publicado: (2015)

Prediagnostic adult body mass index change and esophageal adenocarcinoma survival
por: Loehrer, Elizabeth A., et al.
Publicado: (2020)

SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma
por: Chai, Yuhang, et al.
Publicado: (2019)

Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial‐mesenchymal transition, invasion, and migration
por: Zhao, Yue, et al.
Publicado: (2018)

Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2019)

Real-world treatment patterns and survival for locally advanced esophageal squamous cell carcinoma
por: Luo, Hua-Chun, et al.
Publicado: (2023)

Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival
por: Faluyi, Olusola O., et al.
Publicado: (2017)

AFAP1‐AS1 is upregulated and promotes esophageal squamous cell carcinoma cell proliferation and inhibits cell apoptosis
por: Luo, Hong‐lei, et al.
Publicado: (2016)

Exosomal lncRNA FAM225A accelerates esophageal squamous cell carcinoma progression and angiogenesis via sponging miR‐206 to upregulate NETO2 and FOXP1 expression
por: Zhang, Chunyu, et al.
Publicado: (2020)

The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
por: Lv, Huilai, et al.
Publicado: (2023)

A novel serum microRNA signature to screen esophageal squamous cell carcinoma
por: Huang, Zebo, et al.
Publicado: (2016)

Induction chemotherapy increases efficacy and survival rate of patients with locally advanced esophageal squamous cell carcinoma
por: Huang, Yuting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vbdmub3uu792jt8m05v96hp2ip